BGLAP and myeloproliferative disorder: A significantly decreased expression of OSTERIX was measured in all patient-derived MSCs (Figure 2C), while OSTEOCALCIN was strongly reduced in MPN, ALL, and NHL-derived MSCs, and significantly reduced in MDS and AML-derived MSCs (Figure 2D).